Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for cyclin- dependent kinases
Most Correlated Studies
- T cell acute lymphoblastic leukemia MOLT4 cells treated with cyclin-dependent kinase inhibitors
- Cyclin D1 and CDK4 contribute to the undifferentiated phenotype in neuroblastoma
- Embryonic stem cells, fibroblasts and brain tissues from cyclin C knockout mouse embryos
- NSCLC PC9 cells selected for gefitinib sensitivity or resistance treated with EGF and gefitinib
- Prostate cancer cell line (LNCaP) treated with trichostatin A or roscovitine, or EZH2 knockdown
Most Relevant Literature
- Host CDK-1 and formin mediate microvillar effacement induced by enterohemorrhagic Escherichia coli.
- Compartmentalized control of Cdk1 drives mitotic spindle assembly.
- Targeting cyclin-dependent kinase 1 (CDK1) in cancer: molecular docking and dynamic simulations of p…
- PIN1 and CDK1 cooperatively govern pVHL stability and suppressive functions.
- Inhibition of CDK1 Overcomes Oxaliplatin Resistance by Regulating ACSL4-mediated Ferroptosis in Colo…
Most Relevant Clinical Trials
- Abemaciclib for Bone and Soft Tissue Sarcoma With Cyclin-Dependent Kinase (CDK) Pathway Alteration
- A Study Of Oral Palbociclib (PD-0332991), A Cyclin-Dependent Kinase Inhibitor, In Patients With Adva…
- Evaluation of Skin Health and Quality of Life in Patients Receiving Anti-PD1/PDL1/CTLA4 or Cyclin-de…
- Observational Study in Patients With Cyclin-dependent Kinase-like 5 Deficiency Disorder
- Cyclin Dependent Kinase (CDK)4/6 Inhibitor, PD0332991 in Advanced Non-small Cell Lung Cancer NSCLC.
